Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	32	32	18	35	71	71
Market Cap Growth	18.74%	83.11%	-49.58%	-51.00%	0.31%	93.59%
Enterprise Value	30	31	10	27	58	59
Last Close Price	0.98	1.22	3.12	9.40	30.00	37.00
PB Ratio	1.25	1.45	-77.02	19.53	12.85	7.59
P/TBV Ratio	-	-	-	19.72	12.91	7.61
Debt / Equity Ratio	0.03	0.15	-	-	-	-
Quick Ratio	0.16	0.13	0.84	1.10	1.54	2.69
Current Ratio	0.19	0.15	0.95	1.15	1.91	2.79
Return on Equity (ROE)	-112.02%	-179.92%	-1281.43%	-483.23%	-233.27%	-363.75%
Return on Assets (ROA)	-28.56%	-37.89%	-115.51%	-113.26%	-81.96%	-106.60%
Return on Capital (ROIC)	-67.74%	-82.38%	-1344.91%	-392.89%	-144.04%	-239.31%
Earnings Yield	-38.22%	-61.28%	-56.74%	-50.73%	-24.40%	-24.00%
FCF Yield	-28.11%	-38.87%	-93.17%	-61.47%	-26.40%	-23.82%
Buyback Yield / Dilution	-235.61%	-144.03%	-56.79%	-45.46%	-35.87%	-72.53%

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q